| human | Q5 |
| P6178 | Dimensions author ID | 01310070162.56 |
| P227 | GND ID | 133926494 |
| P496 | ORCID iD | 0000-0001-5891-3441 |
| P3829 | Publons author ID | 2082389 |
| P1053 | ResearcherID | L-2265-2017 |
| P1153 | Scopus author ID | 15835360200 |
| P214 | VIAF ID | 15974692 |
| P69 | educated at | University of Erlangen–Nuremberg | Q40025 |
| University of Jena | Q154561 | ||
| Technical University of Munich | Q157808 | ||
| P108 | employer | Queen Mary University of London | Q195668 |
| Monash University | Q598841 | ||
| Leibniz Institute for Polymer Research | Q1739877 | ||
| Queensland University of Technology | Q1144750 | ||
| P735 | given name | Daniela | Q1096053 |
| Daniela | Q1096053 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q92063602 | 3D approaches to model the tumor microenvironment of pancreatic cancer |
| Q63247737 | 5 Cellular Model Systems to Study the Tumor Biological Role of Kallikrein-related Peptidases in Ovarian and Prostate Cancer |
| Q58551147 | A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns |
| Q57115289 | A Method for Prostate and Breast Cancer Cell Spheroid Cultures Using Gelatin Methacryloyl-Based Hydrogels |
| Q51307766 | A Validated Preclinical Animal Model for Primary Bone Tumor Research. |
| Q34798735 | A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread |
| Q92143320 | A humanized bone microenvironment uncovers HIF2 alpha as a latent marker for osteosarcoma |
| Q38118283 | A multiscale road map of cancer spheroids--incorporating experimental and mathematical modelling to understand cancer progression. |
| Q104076121 | Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy |
| Q36595049 | Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome |
| Q112716305 | Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology |
| Q39667507 | Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells |
| Q41040719 | Biomaterial science meets computational biology |
| Q37670388 | Can tissue engineering concepts advance tumor biology research? |
| Q93090584 | Cell Recovery of Hydrogel-Encapsulated Cells for Molecular Analysis |
| Q39281993 | Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance |
| Q38511127 | Consent for third molar tooth extractions in Australia and New Zealand: a review of current practice. |
| Q38539794 | Convergence of regenerative medicine and synthetic biology to develop standardized and validated models of human diseases with clinical relevance. |
| Q84140965 | Design and fabrication of tubular scaffolds via direct writing in a melt electrospinning mode |
| Q37295300 | Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research |
| Q36233091 | Endosteal-like extracellular matrix expression on melt electrospun written scaffolds |
| Q35195958 | Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses |
| Q51439316 | Functionalization, preparation and use of cell-laden gelatin methacryloyl-based hydrogels as modular tissue culture platforms. |
| Q35109690 | Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system |
| Q45769197 | Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach |
| Q88504086 | Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma |
| Q59808317 | Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone |
| Q36125886 | Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival. |
| Q38967490 | Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application |
| Q39723990 | Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma |
| Q56978924 | Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer |
| Q90983699 | Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer |
| Q33850055 | Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load |
| Q51416608 | Lycopene's Effects on Cancer Cell Functions within Monolayer and Spheroid Cultures. |
| Q63247724 | Magnetic resonance microimaging of cancer cell spheroid constructs |
| Q37480184 | Metastasis of ovarian cancer is mediated by kallikrein related peptidases |
| Q100427101 | Peptide-protein coassembling matrices as a biomimetic 3D model of ovarian cancer |
| Q51663714 | Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1. |
| Q38188878 | Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer |
| Q24306210 | Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells |
| Q39080408 | Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells |
| Q45196235 | Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone |
| Q63247723 | SpheroidSim—Preliminary evaluation of a new computational tool to predict the influence of cell cycle time and phase fraction on spheroid growth |
| Q37654901 | The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts |
| Q38581780 | The kallikrein-related peptidase family: Dysregulation and functions during cancer progression. |
| Q24680417 | The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior |
| Q40911412 | Tissue engineered humanized bone supports human hematopoiesis in vivo |
| Q37310614 | Translating tissue engineering technology platforms into cancer research |
Search more.